Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma. Read more about Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma.
Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers. Read more about Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers.
Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data. Read more about Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data.
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance). Read more about Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT). Read more about Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT).
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143. Read more about Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies. Read more about Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
Surgical advances in the management of brain metastases. Read more about Surgical advances in the management of brain metastases.
SURG-11. Surgery for control of brain metastases after prior checkpoint inhibitor immunotherapy: a single-center series. Read more about SURG-11. Surgery for control of brain metastases after prior checkpoint inhibitor immunotherapy: a single-center series.
Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Read more about Mouse models of glioblastoma for the evaluation of novel therapeutic strategies.
